Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Chronic Heart Failure

  Free Subscription


03.10.2017

4 Am Heart J
2 Am J Cardiol
1 Basic Res Cardiol
1 Circ Cardiovasc Imaging
3 Circ Heart Fail
19 Eur J Heart Fail
3 Hypertension
4 Int J Cardiol
4 J Am Coll Cardiol
3 J Card Fail
1 J Cardiol
1 J Cardiovasc Pharmacol
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am Heart J

  1. GAGGIN HK, Chen-Tournoux AA, Christenson RH, Doros G, et al
    Rationale and design of the ICON-RELOADED study: International Collaborative of N-terminal pro-B-type Natriuretic Peptide Re-evaluation of Acute Diagnostic Cut-Offs in the Emergency Department.
    Am Heart J. 2017;192:26-37.
    PubMed     Text format     Abstract available

  2. ADIR Y, Guazzi M, Offer A, Temporelli PL, et al
    Pulmonary hemodynamics in heart failure patients with reduced or preserved ejection fraction and pulmonary hypertension: Similarities and disparities.
    Am Heart J. 2017;192:120-127.
    PubMed     Text format     Abstract available

  3. CERBIN LP, Ambrosy AP, Mentz RJ
    Building the case for aerobic exercise in ambulatory patients with heart failure and a reduced ejection fraction.
    Am Heart J. 2017;192:e3.
    PubMed     Text format    

  4. TAYLOR R, Dalal H, Davies R, Doherty P, et al
    Cardiac rehabilitation in heart failure with reduced ejection fraction: A "should take it and not leave it" intervention.
    Am Heart J. 2017;192:e1-e2.
    PubMed     Text format    


    Am J Cardiol

  5. HIGGINS D, Otero J, Jefferis Kirk C, Pak J, et al
    Iron Laboratory Studies in Pediatric Patients With Heart Failure from Dilated Cardiomyopathy.
    Am J Cardiol. 2017 Aug 30. pii: S0002-9149(17)31393.
    PubMed     Text format     Abstract available

  6. GOPAL DJ, Hanff TC, Mazurek JA, Grandin WE, et al
    Prognostic Implications of Changes in Albumin Following Left Ventricular Assist Device Implantation in Patients With Severe Heart Failure.
    Am J Cardiol. 2017 Aug 30. pii: S0002-9149(17)31375.
    PubMed     Text format     Abstract available


    Basic Res Cardiol

  7. DASSANAYAKA S, Brainard RE, Watson LJ, Long BW, et al
    Cardiomyocyte Ogt limits ventricular dysfunction in mice following pressure overload without affecting hypertrophy.
    Basic Res Cardiol. 2017;112:23.
    PubMed     Text format     Abstract available


    Circ Cardiovasc Imaging

  8. IVANOV A, Dabiesingh DS, Bhumireddy GP, Mohamed A, et al
    Prevalence and Prognostic Significance of Left Ventricular Noncompaction in Patients Referred for Cardiac Magnetic Resonance Imaging.
    Circ Cardiovasc Imaging. 2017;10.
    PubMed     Text format     Abstract available


    Circ Heart Fail

  9. WRIGHT SP, Moayedi Y, Foroutan F, Agarwal S, et al
    Diastolic Pressure Difference to Classify Pulmonary Hypertension in the Assessment of Heart Transplant Candidates.
    Circ Heart Fail. 2017;10.
    PubMed     Text format     Abstract available

  10. IMAMURA T, Chung B, Nguyen A, Rodgers D, et al
    Decoupling Between Diastolic Pulmonary Artery Pressure and Pulmonary Capillary Wedge Pressure as a Prognostic Factor After Continuous Flow Ventricular Assist Device Implantation.
    Circ Heart Fail. 2017;10.
    PubMed     Text format     Abstract available

  11. TEIGEN LM, John R, Kuchnia AJ, Nagel EM, et al
    Preoperative Pectoralis Muscle Quantity and Attenuation by Computed Tomography Are Novel and Powerful Predictors of Mortality After Left Ventricular Assist Device Implantation.
    Circ Heart Fail. 2017;10.
    PubMed     Text format     Abstract available


    Eur J Heart Fail

  12. BAYES-GENIS A, Lanfear DE, de Ronde MWJ, Lupon J, et al
    Prognostic value of circulating microRNAs on heart failure-related morbidity and mortality in two large diverse cohorts of general heart failure patients.
    Eur J Heart Fail. 2017 Sep 26. doi: 10.1002.
    PubMed     Text format     Abstract available

  13. CANEPA M, Straburzynska-Migaj E, Drozdz J, Fernandez-Vivancos C, et al
    Characteristics, treatments and 1-year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long-Term Registry.
    Eur J Heart Fail. 2017 Sep 26. doi: 10.1002.
    PubMed     Text format     Abstract available

  14. VAN BILSEN M, Patel HC, Bauersachs J, Bohm M, et al
    The autonomic nervous system as a therapeutic target in heart failure: a scientific position statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology.
    Eur J Heart Fail. 2017 Sep 26. doi: 10.1002.
    PubMed     Text format     Abstract available

  15. LUND LH, Svennblad B, Dahlstrom U, Stahlberg M, et al
    Effect of expanding evidence and evolving clinical guidelines on the prevalence of indication for cardiac resynchronization therapy in patients with heart failure.
    Eur J Heart Fail. 2017 Sep 26. doi: 10.1002.
    PubMed     Text format     Abstract available

  16. AGOSTONI P, Paolillo S, Mapelli M, Gentile P, et al
    Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long-term comparison.
    Eur J Heart Fail. 2017 Sep 26. doi: 10.1002.
    PubMed     Text format     Abstract available

  17. LUND LH, Trochu JN, Meyns B, Caliskan K, et al
    Screening for heart transplantation and left ventricular assist system: results from the ScrEEning for advanced Heart Failure treatment (SEE-HF) study.
    Eur J Heart Fail. 2017 Sep 27. doi: 10.1002.
    PubMed     Text format     Abstract available

  18. HAWKINS NM
    Chronic obstructive pulmonary disease and heart failure in Europe-further evidence of the need for integrated care.
    Eur J Heart Fail. 2017 Sep 26. doi: 10.1002.
    PubMed     Text format    

  19. WOLSK E, Kaye D, Borlaug BA, Burkhoff D, et al
    Resting and exercise haemodynamics in relation to six-minute walk test in patients with heart failure and preserved ejection fraction.
    Eur J Heart Fail. 2017 Sep 26. doi: 10.1002.
    PubMed     Text format     Abstract available

  20. VINEREANU D, Margulescu AD
    The fallacy of resting echocardiographic parameters of cardiac function in heart failure with preserved ejection fraction: reply.
    Eur J Heart Fail. 2017 Sep 25. doi: 10.1002.
    PubMed     Text format    

  21. VAN BOVEN N, Kardys I, van Vark LC, Akkerhuis KM, et al
    Serially measured circulating microRNAs and adverse clinical outcomes in patients with acute heart failure.
    Eur J Heart Fail. 2017 Sep 25. doi: 10.1002.
    PubMed     Text format     Abstract available

  22. KOH AS, Tay WT, Teng THK, Vedin O, et al
    A comprehensive population-based characterization of heart failure with mid-range ejection fraction.
    Eur J Heart Fail. 2017 Sep 25. doi: 10.1002.
    PubMed     Text format     Abstract available

  23. SANDERSON JE, Fang F, Wei YX
    The fallacy of resting echocardiographic parameters of cardiac function in heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2017 Sep 25. doi: 10.1002.
    PubMed     Text format    

  24. WONG LL, Richards AM
    Harnessing the power of microRNAs as prognostic biomarkers in acute heart failure.
    Eur J Heart Fail. 2017 Sep 25. doi: 10.1002.
    PubMed     Text format    

  25. TOMPKINS BA, Rieger AC, Florea V, Banerjee MN, et al
    New insights into cell-based therapy for heart failure from the CHART-1 study.
    Eur J Heart Fail. 2017 Sep 25. doi: 10.1002.
    PubMed     Text format    

  26. KRISTENSEN SL, Mogensen UM, Tarnesby G, Gimpelewicz CR, et al
    Aliskiren alone or in combination with enalapril vs. enalapril among patients with chronic heart failure with and without diabetes: a subgroup analysis from the ATMOSPHERE trial.
    Eur J Heart Fail. 2017 Sep 25. doi: 10.1002.
    PubMed     Text format     Abstract available

  27. WELSH P, Kou L, Yu C, Anand I, et al
    Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED-HF study.
    Eur J Heart Fail. 2017 Sep 27. doi: 10.1002.
    PubMed     Text format     Abstract available

  28. MOTIEJUNAITE J, Celutkiene J, Mebazaa A
    The right ventricle drives the progression of heart failure.
    Eur J Heart Fail. 2017 Sep 29. doi: 10.1002.
    PubMed     Text format    

  29. BAYES-GENIS A, Nunez J, Lupon J
    Heart failure with mid-range ejection fraction: a transition phenotype?
    Eur J Heart Fail. 2017 Sep 25. doi: 10.1002.
    PubMed     Text format    

  30. LUPON J, Simpson J, McMurray JJV, de Antonio M, et al
    Barcelona Bio-HF Calculator Version 2.0: incorporation of angiotensin II receptor blocker neprilysin inhibitor (ARNI) and risk for heart failure hospitalization.
    Eur J Heart Fail. 2017 Sep 26. doi: 10.1002.
    PubMed     Text format    


    Hypertension

  31. DENG KQ, Li J, She ZG, Gong J, et al
    Restoration of Circulating MFGE8 (Milk Fat Globule-EGF Factor 8) Attenuates Cardiac Hypertrophy Through Inhibition of Akt Pathway.
    Hypertension. 2017;70:770-779.
    PubMed     Text format     Abstract available

  32. CHANG TI, Reboussin DM, Chertow GM, Cheung AK, et al
    Visit-to-Visit Office Blood Pressure Variability and Cardiovascular Outcomes in SPRINT (Systolic Blood Pressure Intervention Trial).
    Hypertension. 2017 Jul 31. pii: HYPERTENSIONAHA.117.09788.
    PubMed     Text format     Abstract available

  33. WU L, Zhao F, Dai M, Li H, et al
    P2y12 Receptor Promotes Pressure Overload-Induced Cardiac Remodeling via Platelet-Driven Inflammation in Mice.
    Hypertension. 2017;70:759-769.
    PubMed     Text format     Abstract available


    Int J Cardiol

  34. EMDIN M, Aimo A, Passino C, Vergaro G, et al
    Are big data on myocardial infarction enough for small heart failure patients? Lessons from a national registry.
    Int J Cardiol. 2017;248:278-279.
    PubMed     Text format    

  35. KLEBER FX
    Reduced arteriovenous oxygen difference on exercise in heart failure.
    Int J Cardiol. 2017;248:276-277.
    PubMed     Text format    

  36. BUENO H, Martin-Asenjo R
    Acute heart failure after STEMI. Still a problem, still an opportunity for improving care quality.
    Int J Cardiol. 2017;248:274-275.
    PubMed     Text format    

  37. DEL TORTO A, Corrieri N, Vignati C, Gentile P, et al
    Contribution of central and peripheral factors at peak exercise in heart failure patients with progressive severity of exercise limitation.
    Int J Cardiol. 2017;248:252-256.
    PubMed     Text format     Abstract available


    J Am Coll Cardiol

  38. LI JG, Xu H
    Should Beta-Blockers Be Routinely Prescribed for Myocardial Infarction Without Heart Failure or Ventricular Dysfunction?
    J Am Coll Cardiol. 2017;70:1685-1686.
    PubMed     Text format    

  39. GUAZZI M, Bandera F, Ozemek C, Systrom D, et al
    Cardiopulmonary Exercise Testing: What Is its Value?
    J Am Coll Cardiol. 2017;70:1618-1636.
    PubMed     Text format     Abstract available

  40. SCHERRER U, Rexhaj E, Soria R, Meister TA, et al
    Preterm Birth and Risk of Heart Failure: Potential Contribution of Assisted Reproductive Technologies.
    J Am Coll Cardiol. 2017;70:1828-1829.
    PubMed     Text format    

  41. WATANABE S, Ishikawa K, Fish K, Oh JG, et al
    Protein Phosphatase Inhibitor-1 Gene Therapy in a Swine Model of Nonischemic Heart Failure.
    J Am Coll Cardiol. 2017;70:1744-1756.
    PubMed     Text format     Abstract available


    J Card Fail

  42. LI L, Jesdale BM, Hume A, Gambassi G, et al
    Pharmacotherapy Use in Older Patients with Heart Failure and Reduced Ejection Fraction after a Skilled Nursing Facility Stay.
    J Card Fail. 2017 Sep 19. pii: S1071-9164(17)31212.
    PubMed     Text format     Abstract available

  43. YUN JE, Park JE, Park HY, Lee HY, et al
    Comparative Effectiveness of Telemonitoring Versus Usual Care for Heart Failure: a Systematic Review and Meta-Analysis.
    J Card Fail. 2017 Sep 19. pii: S1071-9164(17)31211.
    PubMed     Text format     Abstract available

  44. METIN ZG, Ejem D, Dionne-Odom JN, Turkman Y, et al
    Mind-Body Interventions for Individuals with Heart Failure: a Systematic Review of Randomized Trials.
    J Card Fail. 2017 Sep 19. pii: S1071-9164(17)31213.
    PubMed     Text format     Abstract available


    J Cardiol

  45. KUMAGAI N, Dohi K, Fujimoto N, Tanimura M, et al
    A novel method for the quantitative evaluation of diurnal respiratory instability in patients with heart failure: A pilot study.
    J Cardiol. 2017 Sep 25. pii: S0914-5087(17)30218.
    PubMed     Text format     Abstract available


    J Cardiovasc Pharmacol

  46. ABBATE A, Van Tassell BW
    Levosimendan in advanced heart failure: where do we stand?
    J Cardiovasc Pharmacol. 2017 Sep 25. doi: 10.1097/FJC.0000000000000539.
    PubMed     Text format    


    PLoS One

  47. NAMUKWAYA E, Murray SA, Downing J, Leng M, et al
    'I think my body has become addicted to those tablets'. Chronic heart failure patients' understanding of and beliefs about their illness and its treatment: A qualitative longitudinal study from Uganda.
    PLoS One. 2017;12:e0182876.
    PubMed     Text format     Abstract available

  48. KEDDIS MT, El-Zoghby Z, Kaplan B, Meeusen JW, et al
    Soluble ST2 does not change cardiovascular risk prediction compared to cardiac troponin T in kidney transplant candidates.
    PLoS One. 2017;12:e0181123.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: